AMTI: Applied Molecular Transport Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Applied Molecular Transport Inc.

NASDAQ:AMTI

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$0.26
Loss Chance
58.4%
0.80JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Halozyme Therapeutics
NASDAQ:HALO
6.26
$68.18
56.28%
Incyte Corporation
NASDAQ:INCY
5.05
$97.50
10.91%
Neurocrine Biosciences
NASDAQ:NBIX
7.23
$156.39
36.64%
Organogenesis Holdings
NASDAQ:ORGO
5.30
$2.62
72.59%
Regeneron Pharmaceuticals
NASDAQ:REGN
6.15
$621.52
27.31%
Jitta Factors
Growth Opportunity (9)
Recent Business Performance (34)
Financial Strength (28)
Return to Shareholders (0)
Competitive Advantage (5)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 17.65% in the last year
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.80
100.00%
2.43
400.04%
2.43
400.04%
COMPANY DESCRIPTION
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company’s lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2015 and is headquartered in Gainesville, Florida. As of December 27, 2023, Applied Molecular Transport Inc. operates as a subsidiary of Cyclo Therapeutics, Inc.
www.appliedmt.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.